Fermenta Biotech Ltd (FERMENTA)
🎯 Key Takeaways
- Revenue grew 0.2% QoQ to ₹122 in Q1FY27.
- Market Cap
- ₹1,618
- P/E Ratio
- 26.7
- P/B Ratio
- 3.98
- ROE
- 14.7%
- ROCE
- 18.1%
- Debt/Equity
- 0.27
- Div Yield
- 0.68%
- Promoter
- 64.1%
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 130 | 137 | 122 | 122 |
| Operating Profit | 21 | 20 | 15 | 13 |
| OPM % | 16.3% | 14.3% | 12.3% | 10.6% |
| Net Profit | 18 | 12 | 19 | 10 |
| EPS | ₹6.20 | ₹4.36 | ₹6.66 | ₹3.40 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 15 | 15 | 14 | 15 |
| Reserves | 348 | 276 | 392 | 376 |
| Borrowings | 115 | 125 | 109 | 112 |
| Total Liabilities | 614 | 539 | 648 | 651 |
| Fixed Assets | 219 | 249 | 217 | 213 |
| Investments | 0 | 0 | 4 | 0 |
| Total Assets | 614 | 539 | 648 | 651 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +93 |
| Investing | -43 |
| Financing | -42 |
| Net Cash Flow | +8 |
👥 Shareholding Pattern
| Category | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| Promoters | 64.1% | 64.1% | 64.1% |
| FII | 0.0% | 0.0% | 0.1% |
| DII | 0.0% | 0.0% | 0.0% |
| Public | 29.5% | 28.8% | 28.3% |
| # Shareholders | 14,139 | 13,661 | 14,131 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.37 L Cr | 36.1 | 18.7% | — | 0.05 |
| DIVISLAB | 2.46 L Cr | 84.2 | 23.0% | — | 0.00 |
| TORNTPHARM | 1.83 L Cr | 76.6 | 15.1% | — | 1.76 |
| ZYDUSLIFE | 1.16 L Cr | 25.9 | 16.8% | — | 0.43 |
| CIPLA | 1.09 L Cr | 32.3 | 13.2% | — | 0.01 |
| LAURUSLABS | 1.07 L Cr | 97.8 | 20.8% | — | 0.45 |
| MANKIND | 1.03 L Cr | 50.6 | 13.9% | — | 0.38 |
| DRREDDY | 1.03 L Cr | 31.9 | 10.1% | — | 0.17 |
| AUROPHARMA | 95,887 | 26.0 | 12.8% | — | 0.20 |
| LUPIN | 93,367 | 16.5 | 27.9% | — | 0.26 |
🔗 Peer Stock Analyses
📋 Recent Filings
- 🔴 Insider Trading2026-09-30Ms. Preeti Thakkar, promoter of Fermenta Biotech Ltd, sold 11,65,938 equity shares representing 3.96% of the company's total holdings on September 28,…
- Announcement2026-09-29Fermenta Biotech Ltd announced the closure of its trading window effective October 1, 2026, until 48 hours after the unaudited Q2 FY2026 results annou…
- 🔴 Announcement2026-09-29Fermenta Biotech Ltd announced an investor meeting scheduled for October 5, 2026, in Mumbai, to discuss press releases and investor presentations avai…
- 🔴 Announcement2026-09-24Fermenta Biotech Ltd announced an investor meeting scheduled for September 29, 2026, in Mumbai, offering one-on-one sessions with company officials. T…
- 🔴 Announcement2026-09-21Fermenta Biotech Ltd announced an investor meeting scheduled for September 24, 2026, in Mumbai, to discuss press releases and investor presentations a…
- 🔴 Announcement2026-09-17Fermenta Biotech Ltd announced an investor meeting scheduled for September 22, 2026, in Mumbai, offering one-on-one sessions with company officials. T…
- 🔴 Corporate Action2026-09-16Fermenta Biotech informed shareholders that shares with unclaimed dividends for seven consecutive years, including the 2019-20 interim dividend, will …
- Announcement2026-09-08Fermenta Biotech announced an exclusive licence agreement with VIT Vellore to commercialise a technology that fortifies Vitamin B12 during natural fer…
- 🔴 Announcement2026-08-27Fermenta Biotech Ltd announced it will hold one-to-one investor meetings on September 3, 2026, in Mumbai, to discuss press releases and investor prese…
- 🔴 Announcement2026-08-17Fermenta Biotech Limited announced that CARE Ratings upgraded its long-term bank facilities rating from BBB to BBB+ and short-term facilities from A3+…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when FERMENTA files new disclosures
Track FERMENTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track FERMENTA — FreeFree account · 2 AI queries/day